$ESTA

JW Asset Management, LLC sold $1.9M of ESTA (indirect holdings)

JW Asset Management, LLC sold 25,320 indirectly-held shares of ESTABLISHMENT LABS HOLDINGS INC. (ESTA) at $74.39 ($1.88M total) on 2026-05-26.

Original reporting
SEC EDGAR · JW Asset Management, LLC
Published May 29, 2026, 12:49 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 8:50 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ESTA
Neutral
medium confidence
Mentioned
$ESTA
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ESTANeutralLow
01

Why it matters

This provides a datapoint on institutional selling activity but does not introduce new company fundamentals or external events.

02

Market read

Traders may monitor for follow-on selling or accumulation, but without additional fundamental news the immediate trading edge is limited.

03

What to watch

No disclosure of total position changes beyond holdings after the trade, no rationale for sale, and no linkage to upcoming catalysts—so signal-to-noise is limited.

Relevance 6/10Novelty 6/10Timing: Filed 2026-05-28; sale occurred 2026-05-26 (post-trade disclosure).

Background

The article is an SEC EDGAR Form 4 insider/ownership transaction disclosure for Establishment Labs Holdings Inc.

Company-level read

Ticker impact

$ESTANeutralMedium confidence
Context

SEC Form 4 shows JW Asset Management sold 25,320 shares of Establishment Labs Holdings (ESTA) for ~$1.88M on 2026-05-26.

Expected impact

Low near-term impact; may slightly pressure sentiment if traders interpret as risk reduction, but no new operating/financial catalyst is provided.

Evidence & confidence

The filing is a disclosed sale (code S) with no 10b5-1 plan and no accompanying company-specific news (earnings, guidance, deal, litigation).

Market effects

No clear sector read-through; this is a single-firm ownership transaction without sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

The sale could be routine rebalancing/liquidity needs; absence of a 10b5-1 plan does not necessarily imply negative fundamentals.

Key entities

  • ESTABLISHMENT LABS HOLDINGS INC.

    Subject of the SEC Form 4 ownership transaction; shares sold by JW Asset Management.

  • JW Asset Management, LLC

    Reported the open-market sale of ESTA shares on 2026-05-26.

Related articles

$ESTAMed

Establishment Labs Q2 Earnings Call Highlights

Establishment Labs (NASDAQ:ESTA) reported Q2 updates on its Motiva breast implant business. Outside the U.S. revenue rose 4.4% to $42.8M, with Europe up 16%. Its Minimally Invasive platform generated $12.1M revenue, nearing 15% of full-year global revenue. Gross margin improved to 70.6%. Cash was $71.2M. FDA site audits began for U.S. reconstruction; no material revenue expected until 2027.

$ESTAMed

ESTABLISHMENT LABS HOLDINGS INC. (ESTA): Results of Operations and Financial Condition

ESTABLISHMENT LABS HOLDINGS INC. (ESTA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 estaerq22026-ex991.htm EX-99.1 Document EXHIBIT 99.1 PRESS RELEASE Investor/Media Contact: Malavika William mwilliam@establishmentlabs.com Establishment Labs ® Reports Second Quarter 2026 Financial Results NEW YORK, NY, August 6, 2026 -- Establishment Labs Holdings Inc.